gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced MelanomaSCHWARTZENTRUBER, Douglas J; LAWSON, David H; KENDRA, Kari L et al.The New England journal of medicine. 2011, Vol 364, Num 22, pp 2119-2127, issn 0028-4793, 9 p.Article

Results of a Multicenter, Randomized, Double-Blind, Dose-Evaluating Phase 2/3 Study of Lenalidomide in the Treatment of Metastatic Malignant MelanomaGLASPY, John; ATKINS, Michael B; RICHARDS, Jon M et al.Cancer. 2009, Vol 115, Num 22, pp 5228-5236, issn 0008-543X, 9 p.Article